Skip to main content
Search
Toggle navigation
Hauptnavigation
About
Untermenü für „About“
Vision and Mission
About us
Untermenü für „About us“
GÖG
PPRI
PPI
WHO CC
Team
News
Contact
Expertise
Untermenü für „Expertise“
Pharmaceutical policies
Untermenü für „Pharmaceutical policies“
Pharmaceutical systems research
Pharmaceutical policy analysis
Medicine prices
Untermenü für „Medicine prices“
Legal Mandate
Pharma Price Information (PPI)
European medicine price database (EURIPID)
Research, technical support and trainings
International collaborations
Untermenü für „International collaborations“
PPRI networks
Scientific collaborations
Further collaborations
Medical devices
Untermenü für „Medical devices“
Study supporting the monitoring of availability of medical devices on the EU market
Study on the implementation of Article 17 of Regulation (EU) 2017/745 on medical devices on the EU market
Services
Untermenü für „Services“
Medicine price data
Research
Training
Policy advice
Methodology
Supporting networks
Publications
Untermenü für „Publications“
Studies and analyses
Untermenü für „Studies and analyses“
Articles
Technical reports
Books/book chapters
Working papers
Published abstracts
Posters
PPRI country information
Untermenü für „PPRI country information“
PPRI Profiles / Briefs
PPRI Posters
Methodology documents
Further reading
Glossary
Untermenü für „Glossary“
About Glossary and translations
Online search
Events
DE
Untermenü für „DE“
Wofür wir uns einsetzen
PPRI
Unsere Schwerpunkte
Untermenü für „Unsere Schwerpunkte“
Arzneimittelpolitik
Arzneimittelpreisvergleiche und -analysen
Internationale Vernetzung und Kooperation
Medizinprodukte
Publikationen
Glossar
Veranstaltungen
News
ES
Untermenü für „ES“
Acerca de nosotros
PPRI
Nuestra área de expertís
Untermenü für „Nuestra área de expertís“
Políticas farmacéuticas
Análisis y comparación de precios en medicamentos
Cooperación y trabajo en red internacional
Dispositivos médicos
Publicaciones
Glosario
Eventos
Noticias
RU
Untermenü für „RU“
О нас
PPRI
Наша компетенция
Untermenü für „Наша компетенция“
Исследование систем лекарственного обеспечения
Анализ лекарственной политики
Анализ и сравнение цен на лекарственные средства
Международная сеть и сотрудничество
Изделия медицинского назначения
Публикации
Глоссарий
Мероприятия
Новости
Members
x
close
Glossary
A
|
B
|
C
|
D
|
E
|
F
|
G
|
H
|
I
|
L
|
M
|
N
|
O
|
P
|
R
|
S
|
T
|
U
|
V
|
W
I
International non-proprietary name prescribing
Requirements for prescribers (e.g. physicians) to prescribe a medicine by its INN, i.e. the active ingredient name instead of the brand name. INN…
Internet Pharmacy
Umbrella term for retailers of prescription-only medicines (POM) non-prescription medicines (NPM) that sell their products via the World Wide Web.…
L
Lifecycle management
The practice of brand-name manufacturers seeking to further extend the market exclusivity periods for their medicines to maintain revenue streams.…
List price
The price that suppliers display as the price at which they are prepared to sell their product and/or regulated by legislation. A list price is…
M
Magistral Formula
Any medicine prepared in a pharmacy in accordance with a medical prescription for an individual patient. In German: Magistrale Zubereitung / Formula…
Managed entry agreement (MEA)
An arrangement between a manufacturer and payer/provider that enables access to (coverage/reimbursement of) a health technology subject to specified…
Manufacturer
Natural or legal person with responsibility for the manufacturing of a product. Manufacturing includes all operations of receipt of materials,…
Margin
The percentage of the selling price that is profit. In the case of the pharmaceutical distribution, a wholesale or pharmacy margin is price-dependant…
Marginal cost
Increase or decrease in costs as the result of one more or one less unit of output. Determining marginal cost is important in deciding whether or not…
Mark-up
The mark-up is the percentage of the purchasing price added on to get the selling price. A mark-up is added on to the total cost incurred by the…
Market player
Actors with a commercial interest in the pharmaceutical system. Market players include pharmaceutical manufacturers, distribution actors and…
Marketing Authorisation / Licencing
A licence issued by a medicines agency approving a medicine for market use based on a determination by authorities that the medicine meets the…
Marketing authorisation holder (MAH)
The Marketing Authorisation Holder holds the authorisation to place a medicine on the market and is responsible for marketing it. The marketing…
Marketing authorisation under exceptional circumstances
Services provided by a health care system to a population. They include: - Hospital medical services aimed at curing, restoring and/or maintaining…
Maximum price
An upper threshold provided for by regulation or by tender specifications. Purchasers are not allowed to price above this threshold but have…
Me-too medicine
A medicine approved after a pioneering product. It is defined as comparable or similar but not clinically superior product. In German: Me-too-…
Medical Device
A medical device is any instrument, apparatus, appliance, software, material or other article, whether used alone or in combination, including the…
Medication error
Any preventable event that may cause or lead to inappropriate medication use or patient harm while the medication is in the control of the health…
Medication reconciliation
The process of comparing a patient’s medication orders to all of the medications that the patient has been taking. This reconciliation is done to…
Medication shortage
Lack and/or gaps in the availability of medicines, usually due to problems in the supply chain. This supply issue affects how the pharmacy prepares…
Pagination
First page
« First
Previous page
‹‹
…
Page
3
Page
4
Page
5
Page
6
Current page
7
Page
8
Page
9
Page
10
Page
11
…
Next page
››
Last page
Last »